Omega Therapeutics Inc Cash Flow-to-Debt Ratio
Omega Therapeutics Inc cash flow-to-debt ratio. Omega Therapeutics Inc (OMGA) has a Cash Flow-to-Debt Ratio of -0.10x as of September 2024, meaning its operating cash flow of $-14.02 Million could theoretically repay 0% of its total liabilities ($141.18 Million) in one year. See Omega Therapeutics Inc (OMGA) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Omega Therapeutics Inc (2019–2023)
Cash flow-to-debt ratio of Omega Therapeutics Inc from 2019 to 2023. Historical debt coverage capacity for Omega Therapeutics Inc across 5 annual periods. Also explore OMGA net asset momentum to track the company's year-over-year net asset growth rate.
Omega Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2019–2023)
Omega Therapeutics Inc cash flow-to-debt ratio by year from 2019 to 2023. Year-by-year debt coverage analysis for Omega Therapeutics Inc. For the full cash flow conversion analysis, see OMGA cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.63x | $-91.51 Million | $146.35 Million | ▲ +74.6% |
| 2022 | -2.46x | $-98.52 Million | $40.03 Million | ▼ -39.7% |
| 2021 | -1.76x | $-57.61 Million | $32.70 Million | ▼ -524.9% |
| 2020 | -0.28x | $-26.13 Million | $92.71 Million | ▲ +24.4% |
| 2019 | -0.37x | $-15.68 Million | $42.04 Million | — |